These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6306089)

  • 1. The effect of dietary restriction of varying duration on survival, tumor patterns, immune function, and body temperature in B10C3F1 female mice.
    Cheney KE; Liu RK; Smith GS; Meredith PJ; Mickey MR; Walford RL
    J Gerontol; 1983 Jul; 38(4):420-30. PubMed ID: 6306089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune function and survival in a long-lived mouse strain subjected to undernutrition.
    Gerbase-DeLima M; Liu RK; Cheney KE; Mickey R; Walford RL
    Gerontologia; 1975; 21(4):184-202. PubMed ID: 1102395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host reactivity against clonable tumor cells and the total tumor cell population, studied in a syngeneic murine lymphoma system.
    Gjedde SB
    Acta Pathol Microbiol Immunol Scand C; 1983 Apr; 91(2):101-8. PubMed ID: 6349250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary restriction reduces the incidence of 3-methylcholanthrene-induced tumors in mice: close correlation with its potentiating effect on host T cell functions.
    Konno A; Hishinuma K; Hashimoto Y; Kimura S; Nishimura T
    Cancer Immunol Immunother; 1991; 33(5):293-8. PubMed ID: 1868487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modification of age-related immune decline in mice dietarily restricted from or after midadulthood.
    Weindruch R; Gottesman SR; Walford RL
    Proc Natl Acad Sci U S A; 1982 Feb; 79(3):898-902. PubMed ID: 6977776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced induction of antitumor T-cell responses by cytotoxic T lymphocyte-associated molecule-4 blockade: the effect is manifested only at the restricted tumor-bearing stages.
    Yang YF; Zou JP; Mu J; Wijesuriya R; Ono S; Walunas T; Bluestone J; Fujiwara H; Hamaoka T
    Cancer Res; 1997 Sep; 57(18):4036-41. PubMed ID: 9307290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of mouse immune functions by dietary restriction: an investigation up to 1 year of age.
    Hishinuma K; Nishimura T; Konno A; Hashimoto Y; Kimura S
    Ann Nutr Metab; 1990; 34(2):76-84. PubMed ID: 2369077
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential rate of age-related decline in immune functions in genetically defined mice with different tumor incidence and life span.
    Hirokawa K; Utsuyama M; Goto H; Kuramoto K
    Gerontology; 1984; 30(4):223-33. PubMed ID: 6090273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The retardation of aging in mice by dietary restriction: longevity, cancer, immunity and lifetime energy intake.
    Weindruch R; Walford RL; Fligiel S; Guthrie D
    J Nutr; 1986 Apr; 116(4):641-54. PubMed ID: 3958810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-related neoplasia in a lifetime study of ad libitum-fed and food-restricted B6C3F1 mice.
    Sheldon WG; Bucci TJ; Hart RW; Turturro A
    Toxicol Pathol; 1995; 23(4):458-76. PubMed ID: 7501958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of controlled dietary restriction on immunologic function and aging.
    Weindruch RH; Kristie JA; Cheney KE; Walford RL
    Fed Proc; 1979 May; 38(6):2007-16. PubMed ID: 437143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related changes in the intrinsic rate of apoptosis in livers of diet-restricted and ad libitum-fed B6C3F1 mice.
    Muskhelishvili L; Hart RW; Turturro A; James SJ
    Am J Pathol; 1995 Jul; 147(1):20-4. PubMed ID: 7604880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor factor secreted by T-lymphocytes from tumor-bearing mice.
    Treves AJ; Cohen IR; Feldman M
    J Natl Cancer Inst; 1976 Aug; 57(2):409-14. PubMed ID: 1087347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nutritional modulation of immune responses.
    Good RA; West A; Fernandes G
    Fed Proc; 1980 Nov; 39(13):3098-104. PubMed ID: 6968692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice.
    Schirrmacher V
    Int J Cancer; 1979 Jul; 24(1):80-6. PubMed ID: 314423
    [No Abstract]   [Full Text] [Related]  

  • 16. Transition from T cell protection to T cell enhancement during tumor growth in an allogeneic host.
    Manor Y; Treves AJ; Cohen IR; Feldman M
    Transplantation; 1976 Oct; 22(4):360-6. PubMed ID: 1086538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity against tumour-associated antigens not H-2 restricted.
    Holden HT; Herberman RB
    Nature; 1977 Jul; 268(5617):250-2. PubMed ID: 69992
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intensification of antineoplastic immunity with the use of chemical heterogenization of tumor tissue antigens].
    Korosteleva TA; Movsesian KS; Aleksanian IuT
    Zh Eksp Klin Med; 1974; 14(3):7-10. PubMed ID: 4370925
    [No Abstract]   [Full Text] [Related]  

  • 19. Effector cell stimulation-inhibition of in vitro lymphoma cell DNA synthesis and correlation with in vivo antitumor response.
    Gordon WC; Prager MD
    Cancer Res; 1977 Feb; 37(2):507-13. PubMed ID: 832275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophages in solid tumors. I. Immunologically specific effector cells.
    Van Loveren H; Den Otter W
    J Natl Cancer Inst; 1974 Oct; 53(4):1057-60. PubMed ID: 4139274
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.